April 22, 2024

Geschäftsanbahnungsreise Biotech – Vereinigtes Königreich (London & Cambridge)

Geschäftsanbahnungsreise Biotech – Vereinigtes Königreich (London & Cambridge)
Go back

Geschäftsanbahnungsreise Biotech – Vereinigtes Königreich (London & Cambridge)  

Target group:  German companies from the Biotech sector

Dates:  11–14 May 2026

Target region:  United Kingdom, London, Cambridge and Stevenage

Local partner onsite:  Life Science Integrates (LSI)

Organizer:  Market Entry Program of the Federal Ministry for Economic Affairs and Energy
(BMWE)

Registration deadline:  31 January 2026 (or until all spots are filled)

Vom 11.05. bis zum 14.05.2026 führt in2newmarkets, im Auftrag des Bundesministeriums für Wirtschaft und
Energie (BMWE), eine Geschäftsanbahnungsreise ins Vereinigte Königreich durch. Es handelt sich dabei um eine
projektbezogene Fördermaßnahme. Sie ist Bestandteil der Exportinitiative Gesundheitswirtschaft und wird im
Rahmen des Markterschließungsprogramms für KMU durchgeführt. Zielgruppe sind vorwiegend kleine und mittlere deutsche Unternehmen (KMU).

Anmeldeunterlagen GAB UK Biotech

Infoletter GAB Biotech UK 2026

register now

Our latest News

discover more
Prof. Gudrun Rappold receives medal of honor from the German Society for Human Genetics

Prof. Gudrun Rappold receives medal of honor from the German Society for Human Genetics

Prof. Dr. Gudrun Rappold, senior professor at Heidelberg University’s Medical Faculty, has been awarded the Medal of Honor by the German Society for Human Genetics. The Medal of Honor is the highest award given by the professional association and recognizes outstanding scientific achievements in human genetics as well as special contributions to the advancement of […]

read more
How cancer immunotherapies affect the heart

How cancer immunotherapies affect the heart

The Hector Foundation is providing €1.3 million in funding for an interdisciplinary research project investigating the cardiological side effects of checkpoint inhibitors. The consortium, with partners at Heidelberg University’s Medical Faculty, the German Cancer Research Center, the Max Delbrück Center in Berlin, and the University Medical Center Schleswig-Holstein in Kiel, is investigating why these cancer […]

read more
Early detection contributes to declining breast cancer mortality rates in Europe

Early detection contributes to declining breast cancer mortality rates in Europe

The introduction of mammography screening programs in Europe has significantly changed breast cancer diagnoses, accompanied by a decline in breast cancer mortality rates. This is shown by one of the most comprehensive analyses of population-based data on breast cancer in 21 European countries to date, led by the German Cancer Research Center (DKFZ). The most […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp